Get the Stockscreener App
371.79
1.47%
-5.55
After Hours:
371.79
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Waters Corp stock is traded at $371.79, with a volume of 482.33K.
It is down -1.47% in the last 24 hours and down -9.58% over the past month.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.
See More
Previous Close:
$377.34
Open:
$378.81
24h Volume:
482.33K
Relative Volume:
1.07
Market Cap:
$22.06B
Revenue:
$2.91B
Net Income/Loss:
$622.64M
P/E Ratio:
35.48
EPS:
10.48
Net Cash Flow:
$620.14M
1W Performance:
-1.97%
1M Performance:
-9.58%
6M Performance:
+9.43%
1Y Performance:
+7.44%
1-Day Range:
$369.88
$379.29
1-Week Range:
$362.70
$387.69
52-Week Range:
$279.24
$423.56
Waters Corp Stock (WAT) Company Profile
Name
Waters Corp
Sector
Industry
Phone
(508) 478-2000
Address
34 MAPLE ST, MILFORD, MA
Compare WAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
371.79 | 22.06B | 2.91B | 622.64M | 620.14M | 10.48 |
|
TMO
Thermo Fisher Scientific Inc
|
523.64 | 198.19B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.69 | 148.92B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
126.33 | 36.52B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
437.15 | 35.63B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
184.85 | 33.12B | 15.41B | 1.37B | 2.11B | 7.50 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-01-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Nov-13-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| May-18-22 | Initiated | Barclays | Overweight |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-25-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-07-21 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-17-20 | Upgrade | Cleveland Research | Underperform → Buy |
| Dec-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-28-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Jul-16-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-08-20 | Downgrade | Needham | Hold → Underperform |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Sell |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-09-19 | Downgrade | Barclays | Equal Weight → Underweight |
| Jul-16-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-12-19 | Downgrade | Cleveland Research | Neutral → Underperform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| Jan-24-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-03-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jan-03-19 | Initiated | Needham | Hold |
| Dec-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-18 | Downgrade | Goldman | Neutral → Sell |
| Oct-11-18 | Upgrade | Cleveland Research | Sell → Neutral |
View All
Waters Corp Stock (WAT) Latest News
Waters Corporation Stock Outlook: Is Wall Street Bullish or Bearish? - Nasdaq
WATERS CORP /DE/ SEC 10-K Report - TradingView
Waters Corporation Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart
Is Waters Corporation (WAT) the Best Scientific Instruments Stock to Buy Right Now? - Insider Monkey
Waters Corporation: Instrument Replacement Cycle Momentum, But Valuation Is A Concern - Seeking Alpha
Waters Corporation's SWOT analysis: stock outlook amid mixed signals - Investing.com
Avestar Capital LLC Makes New Investment in Waters Co. (NYSE:WAT) - MarketBeat
Van ECK Associates Corp Sells 625,924 Shares of Waters Co. (NYSE:WAT) - MarketBeat
Waters Corporation (NYSE:WAT) Just Released Its Annual Earnings: Here's What Analysts Think - Yahoo Finance
SFE Investment Counsel Cuts Stock Holdings in Waters Co. (NYSE:WAT) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Increases Stock Holdings in Waters Co. (NYSE:WAT) - MarketBeat
Scotiabank upgrades Waters to 'sector outperform', raises PT - TradingView
Glycomics Market Size Expected to Reach USD 8.66 Bn by 2034 - GlobeNewswire Inc.
Waters upgraded to Outperform at Scotiabank yesterday - TipRanks
Cambiar Investors LLC Sells 135,838 Shares of Waters Co. (NYSE:WAT) - MarketBeat
Waters Corporation Earnings: What To Look For From WAT - MSN
Waters Corp Reports Strong Q4, Optimistic for 2025 - TipRanks
Waters Corp Braces For Weaker Profit Due To Stronger Dollar - Finimize
Waters Corporation (NYSE:WAT) Q4 2024 Earnings Call Transcript - Insider Monkey
Waters Corp (WAT) Q4 2024 Earnings Call Highlights: Strong Pharma and PFAS Growth Amid FX Challenges - Yahoo Finance
Waters Corporation Reports Strong 2024 Financial Results - TipRanks
Waters: Q4 Earnings Snapshot - mySA
Why Waters Corporation (WAT) Stock Is Nosediving - MSN
Waters Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Waters Earnings: 2024 Results and 2025 Outlook as Expected; Shares Overvalued - Morningstar
Waters reports strong Q4 results, but guidance disappoints - MSN
Waters Corporation’s (NYSE:WAT) Q4: Beats On Revenue But Quarterly Revenue Guidance Significantly Misses Expectations By Stock Story - Investing.com Canada
Waters Corp falls on dour quarterly profit outlook - TradingView
Waters forecasts first-quarter profit below estimates on stronger dollar - AOL
Waters Corp Reports Q4 Revenue of $873M, Beating Estimates; GAAP EPS of $3.88 Misses Slightly - GuruFocus.com
Waters Corp. Q4 24 Earnings Conference Call At 8:00 AM ET - Nasdaq
WATERS Earnings Results: $WAT Reports Quarterly Earnings - Nasdaq
Waters Corporation’s (NYSE:WAT) Q4: Beats On Revenue But Quarterly Revenue Guidance Significantly Misses Expectations - Yahoo Canada Finance
Earnings Flash (WAT) WATERS CORPORATION Reports Q4 Revenue $872.7M, vs. FactSet Est of $857.1M - Marketscreener.com
Waters Corp. Q4 Profit Increases, Beats Estimates - Nasdaq
Waters Corporation Reports Fourth Quarter and Full-Year 2024 Financial Results - TradingView
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2024 Financial Results - Yahoo Finance
Waters Corporation Earnings: What To Look For From WAT By Stock Story - Investing.com Canada
Waters Co. (NYSE:WAT) Shares Acquired by GHP Investment Advisors Inc. - MarketBeat
abrdn plc Sells 7,448 Shares of Waters Co. (NYSE:WAT) - MarketBeat
Stocks Showing Rising Market Leadership: Waters Corp Earns 83 RS Rating - Inkl
Waters Corporation Unveils ElectroForce Apex 1: Revolutionizing Mechanical Testing for Advanced Materials - MD+DI
Waters ElectroForce Apex 1 Instrument Offers Increased Versatility, Simplicity, and Speed to Mechanical Testing of Advanced Polymer Materials – Company AnnouncementFT.com - Financial Times
Pacer Advisors Inc. Purchases 734 Shares of Waters Co. (NYSE:WAT) - MarketBeat
Boston Trust Walden Corp Sells 54,352 Shares of Waters Co. (NYSE:WAT) - MarketBeat
Waters Corp Stock (WAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
8.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):